Composition and uses thereof
AssigneeProgen PG500 Series Pty Ltd
InventorKeith Dredge
Life of this patent
Estimating the term…
Abstract
The present invention relates, inter alia, to methods for the prevention or treatment of cancer, and to compositions, combinations and kits for the treatment or prevention of cancer. In one embodiment, the invention provides a method of treating or preventing cancer, comprising administering to a patient in need thereof an immune checkpoint modulator together with a compound of Formula (I): wherein X is SO3M or H, wherein M is any pharmaceutically acceptable cation; and wherein at least 70% of the X groups is SO3M.
Claims19
A method of treating or preventing cancer, comprising administering to a patient in need thereof an immune checkpoint modulator together with a compound of Formula (I):
- wherein X is SO3M or H, wherein M is any pharmaceutically acceptable cation;
- and wherein at least 70% of the X groups is SO3M.
A pharmaceutical composition or combination comprising a compound of Formula (I) and an immune checkpoint modulator;
- wherein the compound of Formula (I) is:
- wherein X is SO3M or H, wherein M is any pharmaceutically acceptable cation;
- and wherein at least 70% of the X groups is SO3M.
A kit comprising a compound of Formula (I) and an immune checkpoint modulator;
- wherein the compound of Formula (I) is:
- wherein X is SO3M or H, wherein M is any pharmaceutically acceptable cation;
- and wherein at least 70% of the X groups is SO3M.
Dependencies are inferred from the claim text.